A pilot integrative knowledgebase for the characterization and tracking of multi resistant Acinetobacter baumannii in Colombian hospitals

Similar documents
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

Outline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010

DRUG-RESISTANT ACINETOBACTER BAUMANNII A GROWING SUPERBUG POPULATION. Cara Wilder Ph.D. Technical Writer March 13 th 2014

Multi-drug resistant Acinetobacter (MDRA) Surveillance and Control. Alison Holmes

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections

Antimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services

New Drugs for Bad Bugs- Statewide Antibiogram

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta

The Search For Antibiotics BY: ASLEY, ELIANA, ISABELLA AND LUNISCHA BSC1005 LAB 4/18/2018

Dr Nata Menabde Executive Director World Health Organization Office at the United Nations Global action plan on antimicrobial resistance

Acinetobacter Outbreaks: Experience from a Neurosurgery Critical Care Unit. Jumoke Sule Consultant Microbiologist 19 May 2010

Available online at ISSN No:

Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units

Appropriate antimicrobial therapy in HAP: What does this mean?

What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh

ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE

International Journal of Research in Pharmacology & Pharmacotherapeutics

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Summary of the latest data on antibiotic resistance in the European Union

Microbiology of War Wounds AUBMC Experience

Summary of unmet need guidance and statistical challenges

Other Enterobacteriaceae

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

Summary of the latest data on antibiotic consumption in the European Union

Twenty Years of the National Antimicrobial Resistance Monitoring System (NARMS) Where Are We And What Is Next?

Concise Antibiogram Toolkit Background

AMR epidemiological situation: ECDC update

Mechanism of antibiotic resistance

Is biocide resistance already a clinical problem?

Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

The European AMR Challenge - strategic views from the human perspective -

Intrinsic, implied and default resistance

Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital

Mono- versus Bitherapy for Management of HAP/VAP in the ICU

Georgios Meletis, Efstathios Oustas, Christina Botziori, Eleni Kakasi, Asimoula Koteli

What s next in the antibiotic pipeline?

Ventilator associated Pneumonia due to Multi Drug Resistant, Colistin-S Acinetobacter baumannii: Successful Revival of Colistin, A Forgotten Drug

Other β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL

PrevalenceofAntimicrobialResistanceamongGramNegativeIsolatesinanAdultIntensiveCareUnitataTertiaryCareCenterinSaudiArabia

Multidrug-Resistant Acinetobacter

BAD BUGS, NEED DRUGS Why Antibiotics Deserve Congress Attention and Immediate Action Infectious Diseases Society of America

EU Research on Antimicrobial drug resistance Anna Lönnroth Sjödén Unit Infectious Diseases, Directorate Health DG Research European Commission

Implementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials

Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland

EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly

2015 Antimicrobial Susceptibility Report

Do clinical microbiology laboratory data distort the picture of antibiotic resistance in humans and domestic animals?

Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.

Multi-Drug Resistant Organisms (MDRO)

Comparison of Antibiotic Resistance and Sensitivity with Reference to Ages of Elders

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

Antimicrobial Susceptibility Profile of E. coli Isolates Causing Urosepsis: Single Centre Experience

LEARNING OBJECTIVES ANTIMICROBIAL USES AND ABUSES INFECTIOUS DISEASE SCARES

Combating Antimicrobial Resistance: The Way Forward

Human health impacts of antibiotic use in animal agriculture

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital

UDC: : :579.22/ :615.28

Internationally indexed journal

Available online at Scholars Research Library. Der Pharmacia Lettre, 2017, 9 (1):85-92

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae

Int.J.Curr.Microbiol.App.Sci (2018) 7(7):

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Witchcraft for Gram negatives

The relevance of Gram-negative pathogens for public health situation in India

(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India

Dr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center,

BACTERIOLOGICAL PROFILE AND ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ISOLATES OF NEONATAL SEPTICEMIA IN A TERTIARY CARE HOSPITAL

Antimicrobial resistance and antimicrobial consumption in Europe

crossm Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-negative pathogens between

Nosocomial Infections: What Are the Unmet Needs

Differences in distribution and drug sensitivity of pathogens in lower respiratory tract infections between general wards and RICU

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

List of Seminars and invited special lectures delivered on behalf of GMERF

Antimicrobial Resistance and Prescribing

Antimicrobial Resistance Initiative

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage

A snapshot of polymyxin use around the world South America

International Activities In Antimicrobial Resistance

Perspective on AnA Global timicrobial Resistance

Antimicrobial Resistance Surveillance in the South African Public Sector

Investigated of ampc in Carbapenem Resistant Gram-Negative Bacteria Isolated from Burned Patients

Antimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali,

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Fighting MDR Pathogens in the ICU

Combating Antibiotic Resistance: New Drugs 4 Bad Bugs (ND4BB) Subtopic 1C. Seamus O Brien and Hasan Jafri Astra Zeneca and MedImmune

Multidrug Resistant Bacteria in 200 Patients of Moroccan Hospital

Public Health Response to Emerging Resistance

Combating Drug-Resistant Infections Globally. Company Presentation

Multi-drug resistant microorganisms

Transcription:

A pilot integrative knowledgebase for the characterization and tracking of multi resistant Acinetobacter baumannii in Colombian hospitals Our funding partners: EPFL Leading House Swiss Bilateral Programmes

The partners Prof. Emiliano Barreto-Hernández Institutode Biotecnología - Universidad Nacional de Colombia, Bogotá, Colombia Dr. Laurent Falquet University of Fribourg and Swiss Institute of Bioinformatics, Fribourg, Switzerland Msc. Jaime Moreno InstitutoNacional De Salud, Bogotá, Colombia

Acinetobacter baumannii Photo Credit: CDC / Janice Carr A.baumannii is a Gram-negative bacterium that can become an opportunistic pathogen in patients with compromised immune systems. In Colombia, it is increasingly found as a hospital -derived infection (nosocomial) carrying multiple drug-resistance genes since 2001. Carbapenems resistance: Meropenem 65,7% in 2013 and 69,2% in 2014 Cyclinsresistance: Tigecycline 0% in 2013 and 4,2% in 2014 Susceptibility to colistin remains high, however, development of resistance has already been detected in some colombian hospitals

General objectives of the project Design and develop a pilot integrative knowledgebase combining clinical, epidemiological and genomic data for tracking the multidrug resistant Acinetobacter baumannii 1. Sequence a collection of A.baumannii isolates, assemble and annotate the draft genomes. A. baumannii (3 954 000 bp) 2. Extract a genomic profile based on the known resistance and virulence genes (using HMMs). 3. Strengthen monitoring and surveillance of healthcare associated infections (HAIs).

120 isolates of A. baumannii Collection of the Microbiology Laboratory Surveillance program for antibiotic resistances from the Colombian Hospitals of all 22 departments From 2012 to May 2015

Analysis of antibiotic resistance profile (VITEK;PHOENIX; KIRBY BAUER) 120 Colombian isolations Extraction of DNA - Resistance genes - Resistance genomic elements Library Whole genome sequencing (80 sequenced genomes) A. baumannii (3 954 000bp)

Bioinformatics Pipeline Quality Control FastQC (1) Cleaning Sickle (2) Assembly SPAdes (3) Rapid prokaryotic Annotation PROKKA & HMMs (4,5,6,7,8) 1. Andrews S. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ 2. Joshi & Fass, 2011 https://github.com/najoshi/sickle 3. Bankevich et al, 2012 Journal of Computational Biology 19(5) (2012), 455-77 4. Seemann T. 2014 Bioinformatics.15;30(14):2068-9 5. McArthur et al, 2013, Antimicrob. Agents Chemother. 57, 3348-57 6. Gibson et al, 2014, The ISME Journal, doi:ismej.2014.106 7. Chen et al, 2016, NAR 44(Database issue):d694-97 8. Llorens et al, 2011, NAR 39 (suppl 1): D70-4 Upload data into knowledgebase

Status of the 80 sequenced genomes 66 A.baumannii 3 A.pittii 1 A.haemoliticus 10 atypical assemblies Sequence typing based on genomic data reveals ST-79 and ST-25 as the major strains with some minor known ST and some new STs. 40 additional strains to be sequenced by the end of the year

Comparative genomics of the 66 A.baumannii strains ST-79 Non ST-79 ST-25

Outreach of the project Publication Saavedra SY, Prada-Cardozo D, Rincón V, Pérez-Cardona H, Hidalgo AM, Gonzalez MN, Reguero MT, Valenzuela de Silva EM, Mantilla JR, Falquet L, Barreto-Hernández E, Duarte C. Whole genome sequence of a Acinetobacter baumanni ST920 Colombian strain co-producer of OXA-72 and OXA-255-like. Genome Announcements (in press) Workshop with 18 participants and publication Falquet L, Calderon-Copete S, Moreno J, Barreto-Hernández E. Report on the Swiss-Colombian workshop, assembly, annotation and comparison of bacterial genomes. EMBnet.journal 2016 (in press)

Funding already obtained following the project From the seed money we applied for funding to the National University of Colombia with the project: CARACTERIZACIÓN GENÓMICA DE CEPAS COLOMBIANAS DE Providencia rettgeri PRODUCTORAS DE METALOBETALACTAMASAS AISLADAS DURANTE EL PERÍODO 2012 2015. (Genomic characterization of Colombian Providencia rettgeri strains producers of metal-betalactamases, collected between 2012-2015) The project was approved for 12 000 USD for a year.

Next steps? Extension of the knowledgebase to other bacterial species (Pseudomonas aeruginosa and Klebsiella pneumoniae) of the ESKAPE group. Application to the R4D open thematic call this winter (CHF500K for 3 years) For a joint project between Paraguay, Colombia and Switzerland.

Thank you for your attention